Impact-focused investors prioritising social and therapeutic outcomes alongside financial returns in psychedelic ventures.
Explore investor stakeholders by type, funding stage, and sector focus across the psychedelic ecosystem.
Investor Finder
Noetic Fund is a Toronto-based venture firm investing in early-stage technologies focused on mental health and wellbeing. Its public materials describe a diversified strategy across novel drug therapeutics, psychedelic-assisted therapies, digital health, medical devices, wearables, and other evidence-backed solutions, with a global outlook and emphasis on early intervention and prevention. The firm is explicitly tied to the psychedelic medicine ecosystem through its own fund announcements, reading list, and portfolio disclosures. Publicly named investments include CaaMTech, the Alexander Shulgin Research Institute, and Damona Pharmaceuticals, which positions Noetic as an active capital provider in psychedelic drug development and adjacent mental health innovation.
Investor Category
Social-Impact Investors
HQ
HQ: Canada
Portfolio Signals
Series A financing · $22m Series A · Sep 15, 2022
Series A financing · $8m+ Series A · Dec 20, 2022